Ken Griffin Bio Sig Technologies, Inc. Call Options Transaction History

Citadel Advisors LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2023 Nov 14, 2023	SELL	$0.4 - $1.39 $18,760 - $65,190	-46,900 Reduced 68.97%	21,100 $10,000
Q2 2023 Aug 14, 2023	BUY	$1.07 - $1.55 $8,132 - $11,780	7,600 Added 12.58%	68,000 $85,000
Q1 2023 May 15, 2023	BUY	$0.42 - $1.4 $7,938 - $26,460	18,900 Added 45.54%	60,400 $68,000
Q4 2022 Feb 14, 2023	SELL	$0.31 - $8.8 $1,519 - $43,120	-4,900 Reduced 10.56%	41,500 $17,000
Q3 2022 Nov 14, 2022	BUY	$0.56 - $6.98 $560 - $6,980	1,000 Added 2.2%	46,400 $30,000

88.1K

Ticker BSGM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 44,814,400
Market Cap $81.6M
Description
BioSig Technologies, Inc., together with its subsidiaries, operates as medical device company. The company's proprietary product includes precise uninterrupted real-time evaluation of electrograms electrophysiology (PURE EP) system, a signal processing platform that combines hardware and software to address known challenges associated to signal ...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.